Cargando…
Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia: abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator
BACKGROUND: More than 50% of patients undergoing lifelong suppressive antiviral treatment for HIV-1 infection develop minor HIV-1-associated neurocognitive disorders. Neurological complications during HIV-1 infection are the result of direct neuronal damage by proinflammatory products released from...
Autores principales: | Mehla, Rajeev, Bivalkar-Mehla, Shalmali, Nagarkatti, Mitzi, Chauhan, Ashok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533742/ https://www.ncbi.nlm.nih.gov/pubmed/23078780 http://dx.doi.org/10.1186/1742-2094-9-239 |
Ejemplares similares
-
A Flavonoid, Luteolin, Cripples HIV-1 by Abrogation of Tat Function
por: Mehla, Rajeev, et al.
Publicado: (2011) -
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
por: Mehla, Rajeev, et al.
Publicado: (2010) -
The Severity of Experimental Autoimmune Cystitis Can be Ameliorated by Anti-CXCL10 Ab Treatment
por: Singh, Udai P., et al.
Publicado: (2013) -
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011) -
CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)